Cti Biopharma Trademark Details
Word Mark | Cti Biopharma |
---|---|
Status | Alive 807 — Su - Non-Final Action - Mailed |
Previous Owners
Serial Number | 86282220 |
---|---|
Status Date | Monday, September 26, 2016 |
Filing Date | Monday, September 26, 2016 |
Attorney | Frances M. Jagla |
Correspondent
Frances M. Jagla
Lane Powell PC
601 S.W. Second Avenue, Suite 2100
Portland OR 97204
Lane Powell PC
601 S.W. Second Avenue, Suite 2100
Portland OR 97204
Case File Statements
Disclaimer with Predetermined Text | "Biopharma" |
---|---|
Goods & Services | Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens |
Goods & Services | Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders |
Goods & Services | Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing |
Pseudo Mark | Cti Bio Pharma |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, May 28, 2014 |
First Use Anywhere | Friday, December 18, 2015 |
First Use In Commerce | Friday, December 18, 2015 |
Primary Code | 005 |
International Class Codes |
041
|
---|---|
U.S. Class Codes | 100, 101, 107 |
Status | 6 — Active |
Status Date | Wednesday, May 28, 2014 |
First Use Anywhere | Saturday, May 31, 2014 |
First Use In Commerce | Saturday, May 31, 2014 |
Primary Code | 041 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Wednesday, May 28, 2014 |
First Use Anywhere | Saturday, May 31, 2014 |
First Use In Commerce | Saturday, May 31, 2014 |
Primary Code | 042 |
Trademark Timeline
-
May 15 2014Trademark application filed with USPTO
-
May 19 2014New Application Entered In Tram
-
May 28 2014New Application Office Supplied Data Entered In Tram
-
May 29 2014Notice of Pseudo Mark E-Mailed
-
May 31 2014First use anywhere for the mark
-
May 31 2014First use in commerce for the mark
-
May 31 2014First use anywhere for the mark
-
May 31 2014First use in commerce for the mark
-
Jul 02 2014Automatic Update of Assignment of Ownership
-
Aug 31 2014Notification of Non-Final Action E-Mailed
-
Aug 31 2014Non-Final Action E-Mailed
-
Aug 31 2014Non-Final Action Written
-
Aug 31 2014Assigned To Examiner
-
Feb 26 2015Teas Response To Office Action Received
-
Mar 06 2015Assigned To Lie
-
Mar 11 2015Teas/email Correspondence Entered
-
Mar 11 2015Correspondence Received In Law Office
-
Apr 29 2015Notification of Final Refusal Emailed
-
Apr 29 2015Final Refusal E-Mailed
-
Apr 29 2015Final Refusal Written
-
Oct 19 2015Correspondence Received In Law Office
-
Oct 19 2015Teas Request For Reconsideration Received
-
Oct 20 2015Teas/email Correspondence Entered
-
Oct 26 2015Approved For Pub - Principal Register
-
Nov 06 2015Law Office Publication Review Completed
-
Nov 25 2015Notification of Notice of Publication E-Mailed
-
Dec 15 2015Official Gazette Publication Confirmation E-Mailed
-
Dec 15 2015Published For Opposition
-
Dec 18 2015First use anywhere for the mark
-
Dec 18 2015First use in commerce for the mark
-
Feb 09 2016Noa E-Mailed - Sou Required From Applicant
-
May 06 2016Attorney Revoked And/or Appointed
-
May 06 2016Teas Revoke/appoint Attorney Received
-
Aug 08 2016Use Amendment Filed
-
Aug 08 2016Extension 1 Filed
-
Aug 08 2016Teas Extension Received
-
Aug 08 2016Teas Statement of Use Received
-
Aug 31 2016Case Assigned To Intent To Use Paralegal
-
Sep 01 2016Statement of Use Processing Complete
-
Sep 01 2016Extension 1 Granted
-
Sep 02 2016Notice of Approval of Extension Request E-Mailed
-
Sep 26 2016Notification of Non-Final Action E-Mailed
-
Sep 26 2016Non-Final Action E-Mailed
-
Sep 26 2016Su - Non-Final Action - Written